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INTRODUCTION
Juvenile hyaline fibromatosis (JHF) is an extremely rare disease
and less than 70 cases of JHF have been reported worldwide (1).
The current name, JHF, was proposed by Kitano in 1976 (2).
JHF is an autosomal recessive disease that is usually detected in
infancy or early childhood. Most JHF patients exhibit gingival
hypertrophy, contracture of various joints, abnormal develop-
ment of the extremities, osteolytic lesions and pinkish macu-
lopapular lesions of the skin. These skin lesions may involve the
nose, cheek, ears, scalp, back or knees; they are not painful, but
they can result in cosmetic sequelae (3, 4). 
Impaired collagen synthesis is thought to be the major patho-
genetic mechanism that’s responsible for this disease. Two sepa-
rate forms of the disease have been proposed: a localized form
that’s characterized by very slow growth of lesions and a dif-
fuse form that’s characterized by large and rapidly growing
tumors (5). The case presented here was the diffuse type and
this is the first reported case of the diffuse type of JHF in Korea.
This study was conducted with the approval of our institutional
review board.  
CASE REPORT
A Korean boy was delivered by cesarean section following an
uneventful, full-term pregnancy. There was no familial history
of consanguineous marriage. He weighed 2,350 g at birth and
he was treated in the neonatal intensive care unit for respiratory
difficulty. There was no other abnormality at birth. At 3 months
of age, dislocation and stiffness of the hip was noted, and he
was treated with an orthosis for 6 months along with additional
rehabilitation therapy because of multiple joint contractures.
Gingival hypertrophy had developed at 10 months and this
caused difficulties with oral feeding. At the time of presentation,
the first skin lesion had appeared in the perianal area. Because
the perianal mass was initially thought to be a hemorrhoid or an
abscess, the patient was treated with sitz bath therapy. At 20
months, he visited the dentist for the treatment of his gingival
hypertrophy and he was finally referred to our institution for
the removal of a soft, painless, slow-growing mandibular mass
that had developed at 12 months and it had grown continually
for the past 6 months. The physical examination revealed a soft
mandibular mass extending from the lower lip to the mandibu-
lar tip. A pinkish maculopapular skin lesion was observed in the
submandibular area and the anterior neck, and a soft, 1-cm
nodular lesion was observed at both nasolabial folds. In addi-
tion, severe gingival hypertrophy and labial nodules were observed
in the oral cavity (Fig. 1A). Simple radiography showed multiple
osteolytic lesions in the skull (Fig. 1B). The fourth and fifth fin-
gers, both knees and the pelvic joints showed flexion contrac-
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tures (Fig. 1C and 1D). An enhancing nodular lesion was observed
in the submental area via computed tomography (Fig. 2A).
Excisional biopsy of the submandibular mass and a gingival
hypertrophic lesion was performed under general anesthesia
when the boy was 22 months old (Fig. 3). Upon periodic acid-
Schiff (PAS) staining and microscopic examination, elastic tis-
sue was rarely observed within the PAS-positive matrix. The
fibroblasts were widely distributed and embedded in an abun-
dant amorphous eosinophilic matrix. The PAS-stained hyaline
material appeared pink (Fig. 4A). Some stromal cells were
observed in the lacuna-like spaces within this material (Fig. 4B).
The final pathological diagnosis was reported as JHF. During the
follow-up, the gingival hypertrophic lesions and the submandibu-
lar masses became larger and they also increased in number.
New scalp masses had developed as well. The submandibular
mass eventually destroyed the mandible and it invaded the C1
vertebra (Fig. 2B). The gingival hypertrophy impeded oral
feeding. When the boy was 32 months old, surgical manage-
ment that included mass excision and gingivectomy was
attempted again. The histological examination showed that
these lesions were consistent with the diagnosis of JHF. Despite
intermittent hospitalization, the patient’s general condition
gradually deteriorated because of nutritional deficiency, ascites,
recurrent pneumonia and anemia. Recurrent pneumonia and
muscular degenerative changes aggravated the boy’s respirato-
ry failure. Sadly, the patient eventually died of hypoglycemia
and cardiogenic shock at 35 months of age while on supportive
care. 
DISCUSSION
JHF is clinically characterized by pinkish papules or subcuta-
Fig. 1. (A) Note the gingival hypertrophy (black arrow) and nodular lesions at the ends of both lips and the nasolabial folds (white arrow). (B)
Multiple osteolytic lesions (arrow) were seen at the skull bone. (C, D) Note the joint contracture and flexion of his 4th and 5th distal interpha-
langeal joints (arrow).  
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neous nodules, osteolytic lesions and gingival hypertrophy.
Gingival hypertrophy is a common finding and as demonstrated
here, this can be severe enough to interfere with proper feeding
and eventually mastication, which can in turn lead to malnutri-
tion, recurrent infections and even death (6, 7). Flexion con-
tracture involving the knees, elbows, fingers and hip joints may
occur when this type of tumor infiltrates the joint capsule.
The primary treatment for the skin and oral lesions is surgical
excision. Radiotherapy was not effective and the long-term
risks of using this modality for treating young patients are well
understood. Symptomatic management of the oral lesions
includes the extraction of the mobile and carious teeth, and
performing gingivectomy provides only short-term benefit and
this typically requires several treatments (6). Joint contracture is
often associated with a poor prognosis, and capsulotomy, phys-
iotherapy and corticosteroid therapy have all been applied with
only modest success (2, 7, 8). The improvement via capsuloto-
my is known to be temporary, and the patient can be left with
permanent joint contracture and deformity (2).
The laboratory findings for JHF are nonspecific and so they of
little diagnostic use. Hypochromic anemia has been reported in
several of these patients and it is likely related to malnutrition
(9). The differential diagnosis inclu-des gingival fibromatosis,
infantile systemic hyalinosis (ISH), congenital generalized fibro-
Fig. 3. (A) Note the preoperative gingival hypertrophy (arrow). (B) The buried teeth were clearly visible after resection of the excessive gingival
tissue.
A B
Fig. 2. (A) A nodular lesion with enhancement was located at the submental area. (B) The mandible rami were destroyed by the fibroma. The C1
vertebra showed severe destruction.
A B
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Fig. 4. (A) The matrix was positively stained with PAS stain, and elastic tissue was completely absent on the microscopic examination (×400).
(B) Ultrathin sectioning showed dermal collagen with fibroblasts in the background of the hyaline material. Ghost cells that lacked a nucleus are
shown. Exocytosis of the epidermis was seen on microscopic examination (×400).
A B
matosis and Winchester syndrome. Gingival fibromatosis is lim-
ited to the gingiva and the lesions typically consist of connective
tissue that is rich in collagen I (10). ISH has very similar clinical
manifestations and histological findings. However, ISH also
includes diffuse thickening of the skin, the development of
hyperpigmented plaques on bony prominences, diarrhea as a
result of hyalinized growths in the gastrointestinal tract, fre-
quent severe infections and a fatal outcome (11). Congenital
generalized fibromatosis is characterized by multiple dermal
and subcutaneous nodules, visceral involvement and death
shortly after birth (12). Finally, Winchester syndrome is charac-
terized by a short stature, generalized osteoporosis, contrac-
tures of small joints and corneal opacities. Skin lesions are uncom-
mon and there is no deposition of a hyaline matrix (3). For our
patient, the diagnosis of JHF was based on the presence of typi-
cal tumoral skin lesions, gingival hyperplasia, osteolytic bone
lesions, joint contracture, muscle weakness and the characteris-
tic histopathological findings. The presence of amorphous hya-
line material in the dermis supported our diagnosis of JHF (13-
15).
Among the reports concerned with JHF, a few of them described
that the patients died of their disease. Our patient had been seen
by several departments in our hospital since the age of 3 months
old, but the final diagnosis was eventualry made at 22 months
old by otolaryngologists. At that time, the disease had already
infiltrated so many organs upon presentation, including the
scalp, fingers, face and bones, and we had difficulty in providing
approprlate management. Intralegional steroid injection wasn’t
considered because JHF patients showed a limited response in
the early disease stage (2). Gingivectomy temporarily improved
the amount of oral intake, but was not enough to recover patient’s
nutritional deficiency. When the malnutrition was not
improved sufficiently via gingivectomy, parenteral feeding such
as tube feeding, gastrostomy and placing a central line should
be considered. The chance to achieve a good result from
surgery is reduced as the disease becomes more advanced. Our
case proved that Early surgical excision that’s performed when
the lesions are small has proved most effective. Therefore,
making an early diagnosis and administering early treatment
are important and we believed that otolaryngologists have a
key role to make a diagnosis and manage these patients’ oral
feeding.
Some studies have reported strong evidence for the presence
of a deleterious mutation in the capillary morphogenesis gene 2
(CMG2) located on chromosome 4q21 (16, 17). Identifying the
gene mutation that is responsible for this condition will be impor-
tant in the future as this will give researchers insight into the
fundamental defect that is responsible for this hard-to-treat mal-
ady. This may be the key to providing physicians with advanced
and effective treatment for helping these patients.
JHF is a very rare genetic disease. Physicians should consider
the diagnosis of JHF when a young patient presents with multi-
ple maculopapular skin lesions, gingival hypertrophy and joint
contracture. Early diagnosis and surgical intervention, including
the proper supportive care, may be the best strategy for man-
aging this rare disease.
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